Medicus Pharma to Present Clinical Progress at BIO International Conference 2026

Jun 22, 2026

Medicus Pharma (NASDAQ: MDCX) has announced its participation in the 2026 BIO International Conference, taking place June 22–25 in San Diego, California. During the event, Dr. Faisal Mahmood, the company’s Chief Medical Officer, will present updates highlighting recent clinical, regulatory, and strategic developments across Medicus Pharma’s therapeutic pipeline.

As a biotechnology company focused on advancing novel therapeutic assets through clinical development, Medicus continues to expand its portfolio with the goal of bringing innovative treatments to patients while advancing key regulatory and commercialization milestones.

#MedicusPharma
#MDCX
#BIO2026
#BIOInternational
#Biotech
#ClinicalDevelopment
#ClinicalTrials
#Healthcare
#LifeSciences
#DrugDevelopment
#MedicalInnovation
#Pharmaceuticals
#NASDAQ
#JaneKing
#NewsOut